FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

420873008: Prolonged-release suspension for injection (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3633815017 Prolonged-release suspension for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3633816016 Extended-release suspension for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3633817013 Prolonged-release suspension for injection (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release suspension for injection Is a Suspension for injection false Inferred relationship Some
Prolonged-release suspension for injection Has dose form administration method (attribute) A method of administration of a dose form by introducing it into the body, usually after puncturing the skin; typically used for small volumes of liquid administered over a brief duration. true Inferred relationship Some
Prolonged-release suspension for injection Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration by injection. true Inferred relationship Some
Prolonged-release suspension for injection Has basic dose form (attribute) A liquid dose form consisting of a suspension of fine particles in a suitable vehicle. true Inferred relationship Some
Prolonged-release suspension for injection Is a Parenteral dose form (dose form) true Inferred relationship Some
Prolonged-release suspension for injection Has dose form release characteristic (attribute) A release characteristic where a dose form displays a slower release of the active substance(s) than that of a conventional-release dose form. This may be achieved by a special formulation design, manufacturing process or other methods. true Inferred relationship Some
Prolonged-release suspension for injection Has dose form transformation (attribute) No transformation true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Cabotegravir 200 mg/mL prolonged-release suspension for injection Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Some
Rilpivirine 300 mg/mL prolonged-release suspension for injection Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Some
Product containing precisely paliperidone (as paliperidone palmitate) 200 milligram/1 milliliter prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Some
Estradiol cypionate 10 mg/mL and medroxyprogesterone acetate 50 mg/mL prolonged-release suspension for injection Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Some

This concept is not in any reference sets

Back to Start